NPI: 1386888279 · CLIFFWOOD, NJ 07721 · Clinic/Center · NPI assigned 04/23/2009
Authorized official FARLEY, BRIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | FARLEY, BRIAN (VP & SECRETARY) |
| Parent Organization | ACADIA HEALTHCARE COMPANY, INC |
| NPI Enumeration Date | 04/23/2009 |
Other providers sharing the same authorized official: FARLEY, BRIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,405 | $1.99M |
| 2019 | 38,151 | $2.31M |
| 2020 | 39,950 | $2.59M |
| 2021 | 34,607 | $2.61M |
| 2022 | 44,574 | $2.48M |
| 2023 | 42,823 | $2.83M |
| 2024 | 32,964 | $2.63M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 134,366 | 28,048 | $10.25M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 46,032 | 13,244 | $5.12M |
| 90791 | Psychiatric diagnostic evaluation | 2,124 | 2,105 | $353K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 13,057 | 12,679 | $352K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 9,029 | 4,488 | $345K |
| G2068 | Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 1,076 | 350 | $216K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,085 | 1,022 | $129K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,379 | 1,143 | $123K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 960 | 954 | $112K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based assessment, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, physical activity and/or nutrition needs and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code | 253 | 245 | $110K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 34,274 | 20,474 | $85K |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | 16,623 | 10,172 | $75K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 570 | 72 | $62K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 609 | 520 | $44K |
| G0434 | Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 1,770 | 1,407 | $28K |
| G2079 | Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 139 | 67 | $16K |
| H0033 | Oral medication administration, direct observation | 78 | 24 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 119 | 109 | $6K |
| 81025 | 1,931 | 1,709 | $6K |